Clinical Trials Logo

Solid Organ Malignancies clinical trials

View clinical trials related to Solid Organ Malignancies.

Filter by:
  • None
  • Page 1

NCT ID: NCT05719428 Recruiting - Clinical trials for Solid Organ Malignancies

Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies

DRUID
Start date: August 28, 2023
Phase: Phase 2
Study type: Interventional

DRUID is a treatment decision support tool combining predictive models and public databases related to multi-gene markers, drug response screens, gene essentiality and clinical status of drugs to provide drug recommendations personalized based on an input genomic profile. We hypothesize that DRUID analysis of patients' somatic mutational profile from NGS diagnostic platform can be used as a treatment decision support tool in patients with refractory cancer without targetable mutations.

NCT ID: NCT01218555 Completed - Clinical trials for Neuroendocrine Tumors

Study of Everolimus (RAD001) in Combination With Lenalidomide

Start date: September 9, 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to study the combination of two anticancer drugs, everolimus (RAD001) and lenalidomide in patients whose cancer is no longer responding to standard treatment or patients who are unable to tolerate the standard treatment for their cancer.